Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach

被引:118
作者
Soema, Peter C. [1 ]
Willems, Geert-Jan [1 ]
Jiskoot, Wim [2 ]
Amorij, Jean-Pierre [1 ]
Kersten, Gideon F. [1 ,2 ]
机构
[1] Intravacc Inst Translat Vaccinol, Bilthoven, Netherlands
[2] Leiden Univ, Leiden Acad Ctr Drug Res, Div Drug Delivery Technol, Leiden, Netherlands
关键词
Liposomes; Cationic lipids; Design of experiments; Prediction models; Dendritic cells; Maturation markers; CATIONIC LIPOSOMES; VACCINE IMMUNOGENICITY; SYSTEMATIC DESIGN; FORMULATION; ADJUVANTS; RESPONSES; PEPTIDE; ANTIGEN;
D O I
10.1016/j.ejpb.2015.06.026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, the effect of liposomal lipid composition on the physicochemical characteristics and adjuvanticity of liposomes was investigated. Using a design of experiments (DoE) approach, peptide-containing liposomes containing various lipids (EPC, DOPE, DOTAP and DC-Chol) and peptide concentrations were formulated. Liposome size and zeta potential were determined for each formulation. Moreover, the adjuvanticity of the liposomes was assessed in an in vitro dendritic cell (DC) model, by quantifying the expression of DC maturation markers CD40, CD80, CD83 and CD86. The acquired data of these liposome characteristics were successfully fitted with regression models, and response contour plots were generated for each response factor. These models were applied to predict a lipid composition that resulted in a liposome with a target zeta potential. Subsequently, the expression of the DC maturation factors for this lipid composition was predicted and tested in vitro; the acquired maturation responses corresponded well with the predicted ones. These results show that a DoE approach can be used to screen various lipids and lipid compositions, and to predict their impact on liposome size, charge and adjuvanticity. Using such an approach may accelerate the formulation development of liposomal vaccine adjuvants. (C) 2015 The Authors. Published by Elsevier B.V.
引用
收藏
页码:427 / 435
页数:9
相关论文
共 26 条
[1]   Towards tailored vaccine delivery: Needs, challenges and perspectives [J].
Amorij, Jean-Pierre ;
Kersten, Gideon F. A. ;
Saluja, Vinay ;
Tonnis, Wouter F. ;
Hinrichs, Wouter L. J. ;
Slutter, Bram ;
Bal, Suzanne M. ;
Bouwstra, Joke A. ;
Huckriede, Anke ;
Jiskoot, Wim .
JOURNAL OF CONTROLLED RELEASE, 2012, 161 (02) :363-376
[2]  
Brewer JM, 1998, J IMMUNOL, V161, P4000
[3]   Molecular mechanisms of T cell co-stimulation and co-inhibition [J].
Chen, Lieping ;
Flies, Dallas B. .
NATURE REVIEWS IMMUNOLOGY, 2013, 13 (04) :227-242
[4]  
Christensen D, 2011, EXPERT REV VACCINES, V10, P513, DOI [10.1586/ERV.11.17, 10.1586/erv.11.17]
[5]   Liposome-based cationic adjuvant formulations (CAF): Past, present, and future [J].
Christensen, Dennis ;
Agger, Else Marie ;
Andreasen, Lars Vibe ;
Kirby, Daniel ;
Andersen, Peter ;
Perrie, Yvonne .
JOURNAL OF LIPOSOME RESEARCH, 2009, 19 (01) :2-11
[6]   Dendritic cell-targeted vaccines [J].
Cohn, Lillian ;
Delamarre, Lelia .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[7]   Formulation optimization of itraconazole loaded PEGylated liposomes for parenteral administration by using design of experiments [J].
Curic, Anamarija ;
Reul, Regina ;
Moeschwitzer, Jan ;
Fricker, Gert .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 448 (01) :189-197
[8]   The Experimental Design as Practical Approach to Develop and Optimize a Formulation of Peptide-Loaded Liposomes [J].
Ducat, Emilie ;
Brion, Michael ;
Lecomte, Frederic ;
Evrard, Brigitte ;
Piel, Geraldine .
AAPS PHARMSCITECH, 2010, 11 (02) :966-975
[9]  
Eriksson L., 2008, Design of Experiments-Principles and Applications
[10]   A role for liposomes in genetic vaccination [J].
Gregoriadis, G ;
Bacon, A ;
Caparros-Wanderley, W ;
McCormack, B .
VACCINE, 2002, 20 :B1-B9